"Let food be your medicine, and let medicine be your food" Hippocrates (^^ - 500BC)
|
Nutri Pharma ASAKronprinsesse Marthas
Plass 1 P.O Box 1477, Vika N-0116 Oslo Norway Telephone +47 23 01 09 60 Telefax +47 23 01 09 70 Send e-mail |
Changed Financial Calendar 201005.03.2010 - Due to changed plan for Board Meetings in Nutri Pharma ASA the release of Q2 for 2010 is postponed from 26(th)
of August, to 31(st) of August 2010....
Approved supplemental prospectus26.02.2010 - Oslo Børs has approved following supplemental
prospectus:
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
Supplemental prospectus
CORRECTION: FOURTH QUARTER AND PRELIMINARY 2009 RESULTS23.02.2010 - This is a correction of the announcement from 19:02 23.02.2010 CET. Reason for the correction: The attached file
appeared in zip-format for some receipients. Please see the Q4 report in a pdf-format instead....
FOURTH QUARTER AND PRELIMINARY 2009 RESULTS23.02.2010 - Turnover from sale to Nikken was for FY 2009 MNOK 14.1. Nikken topped up its inventories in conjunction with
the launch in May 2009...
Mandatory notification of trade22.01.2010 - KAG AS a company fully owned and controlled by Birger Sørensen CEO of Bionor Immuno AS (a subsidiary of Nutri
Pharma ASA), has has today purchased 90.000 NUT
shares at NOK 2.10 per share....
New Primary insiders in NUT 19 February 201019.02.2010 - Reference is made to the stock exchange notification published by 18 February 2010 regarding primary insiders
in Nutri Pharma ASA ("NUT")....
Approved prospectus19.02.2010 - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA. Please
visit this link to access the prospectus.....
Commencement of subscription period for subsequent offering19.02.2010 - Reference is made to stock exchange notice 18
February 2010 regarding completion of private placement in Nutri Pharma ASA ("NUT" or the "Company") of 50 million shares
(the "Private Placement") as well as previous stock exchange notices....
Approved prospectus18.02.2010 - Offering and listing of up to 10,000,000 Subsequent Offering Shares each with a nominal value of NOK 0.25 in
connection with a repair offering to
Eligible Shareholders at a subscription price of NOK
2.00 raising total gross proceeds of up to NOK
20,000,000...
Share capital increase and registrations in the Norwegian Register of Business Enterprises18.02.2010 - Reference is made to the stock exchange notice of 12 February 2010 regarding the extraordinary general
meeting of Nutri Pharma ASA (the "Company"),.....
Notice of EGM resulutions12.02.2010 - At the Extraordinary General Meeting (EGM) of Nutri Pharma ASA held in Oslo on Friday February 12, 2010, all
of the resolutions proposed by the Board were duly
passed...
Nutri Pharma announces candidates proposed for election to the Board of Directors at the EGM 12 February, 201009.02.2010 - The proposed new Board of Directors will have complementary experience within business, law, and medicine suited
to undertake the tasks...
TRANSACTION RELATING TO THE VOLUNTARY OFFER OF ALL THE SHARES IN BIONOR IMMUNO AS05.02.2010 - On 14 January 2010, Nutri Pharma ASA ("NUT" or " Nutri Pharma") submitted a voluntary offer to purchase all of
the shares and warrants in Bionor Immuno AS ("BI"
or "Bionor Immuno")...
Ex-date in Subsequent offering I Nutri Pharma ASA01.02.2010 - Reference is made to the stock exchange release dated today regarding Nutri Pharma ASA ("the Company") successfully
raising NOK 100 million in a
contemplated Private Placement...
Thorleif Krarup proposed as new Chairman of Nutri Pharma ASA25.01.2010 - Thorleif Krarup to be proposed as new Chairman of the Board in Extraordinary Shareholders Meeting to be held
on February 12...
Private Placement23.01.2010 - Nutri Pharma ASA refers to stock exchange release dated 21 January regarding contemplated private placement as
a condition for the completion of the offer to
shareholders in Bionor...
Extraordinary shareholders meeting22.01.2010 - Notice for extraordinary shareholders meeting Nutri Pharma has today sent the attached notice to shareholders
of the company....
Status Offer for shares in Bionor Immuno; contemplated private placement21.01.2010 - With reference to the release 20 January and the release 12 January and theoffer document for offer to shareholders
in Bionor Immuno AS (the "Offer"), Nutri Pharma ASA ("Nutri Pharma" or the "Company")...
Offer for shares in Bionor Immuno AS20.01.2010 - With reference to the release 12 January and the offer document for offer to shareholders in Bionor Immuno, Nutri
Pharma announces that it has received
acceptances for 96,54% of the shares in Bionor Immuno...
Mandatory notification of trade18.01.2010 - Board member Lars H. Høie has today purchased 2.000.000 NUT shares at NOK 2.81 per share....
Voluntary offer from Nutri Pharma ASA to purchase shares in Bionor Immuno AS14.01.2010 - Nutri Pharma ASA ("Nutri Pharma") hereby presents the voluntary offer to purchase shares in Bionor Immuno AS
("Bionor")....
Nutri Pharma ASA to launch a voluntary offer for vaccine developer Bionor Immuno AS12.01.2010 - Nutri Pharma ASA ("Nutri Pharma") to submit a voluntary exchange offer ("Offer") for all outstanding shares in
Bionor Immuno AS("Bionor"). The shareholders of Bionor will be offered 1 Nutri Pharma share per 2 shares in Bionor...
|
2006 Nutri Pharma ASA Telephone +47 23 01 09 60 Telefax +47 23 01 09 70
Contact Page
